Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase ®)
ConclusionWe identified possible associations with some adverse fetal and neonatal outcomes, suggesting that vigilance is required when prescribing certain biologics during pregnancy.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Abatacept | Actemra | Autoimmune Disease | Databases & Libraries | Drugs & Pharmacology | Enbrel | Humira | International Medicine & Public Health | Orencia | Perinatology & Neonatology | Pregnancy | Premature Birth | Remicade | Rituxan | Stelara | WHO | Women